IRIS
STROMILLO, MARIA LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.173
EU - Europa 6.486
AS - Asia 3.108
SA - Sud America 590
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.091
GB - Regno Unito 1.825
RU - Federazione Russa 1.207
CN - Cina 1.168
SG - Singapore 1.023
IE - Irlanda 805
IT - Italia 691
BR - Brasile 505
SE - Svezia 451
UA - Ucraina 434
FR - Francia 338
HK - Hong Kong 310
DE - Germania 299
KR - Corea 185
FI - Finlandia 158
VN - Vietnam 152
ES - Italia 67
IN - India 66
NL - Olanda 57
TR - Turchia 40
BE - Belgio 38
CA - Canada 38
AR - Argentina 27
MX - Messico 27
BD - Bangladesh 23
ZA - Sudafrica 23
JP - Giappone 22
AT - Austria 17
PL - Polonia 16
MK - Macedonia 15
CO - Colombia 14
EC - Ecuador 14
IQ - Iraq 13
CI - Costa d'Avorio 12
ID - Indonesia 12
PH - Filippine 11
CZ - Repubblica Ceca 10
PK - Pakistan 10
IR - Iran 9
MA - Marocco 9
CL - Cile 8
IL - Israele 8
JO - Giordania 8
VE - Venezuela 8
AU - Australia 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
SA - Arabia Saudita 6
EU - Europa 5
KE - Kenya 5
KZ - Kazakistan 5
RS - Serbia 5
BG - Bulgaria 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
HU - Ungheria 4
PY - Paraguay 4
RO - Romania 4
UZ - Uzbekistan 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BB - Barbados 3
JM - Giamaica 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
UY - Uruguay 3
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 18.424
Salva come PNG Salva come JPEG
Città #
Southend 1.639
Dallas 984
Fairfield 959
Dublin 799
Ashburn 599
Singapore 569
Chandler 469
Woodbridge 468
Menlo Park 439
Santa Clara 423
Houston 384
Wilmington 378
Seattle 364
Jacksonville 355
Cambridge 331
Beijing 321
Moscow 305
Hong Kong 302
Hefei 181
Seoul 180
Siena 177
Princeton 165
Ann Arbor 163
Nanjing 118
Milan 107
Los Angeles 102
New York 71
The Dalles 68
Helsinki 64
Boardman 58
Málaga 51
San Mateo 51
São Paulo 49
San Diego 46
Florence 41
Dong Ket 40
Nanchang 38
Buffalo 37
Lancaster 37
Ho Chi Minh City 35
Shenyang 35
London 34
Columbus 33
Hanoi 31
Rome 30
Council Bluffs 28
Munich 28
Brussels 27
Redondo Beach 26
Tianjin 26
Bengaluru 23
Düsseldorf 23
Shanghai 23
Norwalk 22
Changsha 20
Hebei 19
Kunming 19
Jiaxing 18
Tokyo 18
Toronto 18
Chicago 17
Jinan 17
Phoenix 17
Rio de Janeiro 17
San Francisco 17
Belo Horizonte 16
Stockholm 16
Dearborn 15
Pisa 15
Boston 14
Denver 14
Frankfurt am Main 14
Lappeenranta 14
Johannesburg 13
Warsaw 13
Abidjan 12
Fremont 12
Izmir 12
Nuremberg 12
Orem 12
Turku 12
Brooklyn 11
Guarulhos 11
Washington 11
Zhengzhou 11
Amsterdam 10
Brasília 10
Campinas 10
Chennai 10
Poplar 10
Waanrode 10
Falkenstein 9
Genoa 9
Ningbo 9
Amman 8
Hangzhou 8
Kilburn 8
Mexico City 8
Querétaro 8
Sacramento 8
Totale 12.948
Salva come PNG Salva come JPEG
Nome #
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 313
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 301
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 282
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 262
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 251
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 247
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 246
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 242
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 239
Automated identification of brain new lesions in multiple sclerosis using subtraction images 239
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 238
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 231
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 231
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 228
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 227
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 225
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 224
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 222
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 220
Cortical lesions in radiologically isolated syndrome. 219
Assessing response to interferon-β in a multicenter dataset of patients with MS 219
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 219
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 213
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 213
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 213
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 212
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 212
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 211
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 211
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 204
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 203
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 201
Scoring treatment response in patients with relapsing multiple sclerosis 197
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 195
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 194
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 193
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 192
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 192
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 191
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 190
Leukoencephalopathy as a rare complication of hepatitis C infection. 188
The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: A Screening Tool to Select Patients for NOTCH3 Gene Analysis. 186
null 182
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 181
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 180
Deep gray matter volume loss drives disability worsening in multiple sclerosis 180
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 179
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. 179
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 179
Diffuse structural and metabolic brain changes in Fabry disease 176
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 176
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study 176
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis 176
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO) 175
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 172
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 171
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 170
MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. 170
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene. 168
Impaired vasoreactivity in mildly disabled CADASIL patients 165
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 164
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 164
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 164
Refining response to treatment as defined by the Modified Rio Score 160
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial 156
Modelling the distribution of cortical lesions in multiple sclerosis 156
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. 154
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 154
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 154
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 149
Imaging neuronal and axonal degeneration in multiple sclerosis. 147
Retinal nerve fibre layer thickness, lesional load and brain atrophy in patients with cerebral autosomal dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL) 145
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 144
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course 144
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 143
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 141
Leukoencephalopathy, cerebral calcifications, and parenchimal cysts in two siblings. 140
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 138
Mapping the progressive treatment-related reduction of Active MRI lesions in multiple sclerosis 137
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 136
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 132
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 129
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 123
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 122
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 122
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. 120
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 119
null 117
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 117
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 114
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 110
null 108
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm 108
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 106
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 103
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 103
null 102
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 101
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series 100
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 99
Totale 17.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.431 0 0 0 0 0 175 231 358 178 163 177 149
2021/20221.441 107 148 99 101 110 70 79 50 79 124 205 269
2022/20231.778 111 151 235 225 160 336 51 155 204 67 53 30
2023/20241.202 61 25 110 48 35 331 429 26 6 25 24 82
2024/20252.931 71 125 240 148 388 164 129 197 230 148 311 780
2025/20264.376 563 920 846 715 1.184 148 0 0 0 0 0 0
Totale 18.705